US digital pathology market is expected to grow at a CAGR of approximately 14.3% during the forecast period. Digital Pathology offers many advantages to the healthcare sector such as precise diagnosis of the diseases and consultation for quality assurance. The US market is mainly driven by adoption of WSI for cancer diagnosis and research and initiatives for digitization in healthcare sector. Cancer diagnosis is totally depending on traditional pathology of glass slide and therefore WSI has the potential growth in the market. Whole slide imaging is a technology which is used to view, manipulate, and share the digital slides to different platforms. 

Visit for Global Digital Pathology Market Report at: https://www.omrglobal.com/industry-reports/digital-pathology-market

The benefits offered by WSI include access to the digital slides by automated scanning of glass slides. In the US FDA have approved WSI for specific and limited application such as automated cell-locating devices and quantification of immunohistochemistry which indirectly boosting the demand for digital pathology. According to American cancer society a total of 1.69 million of new cancer cases were diagnosed in 2017.Itis expected to rise the demand for digital pathology in the US as the use of WSI enables to detect areas of cancer. Therefore, FDI has also allowed the use of WSI for cancer, which is further contributing to the growth of US digital pathology market. 

Moreover, growing FDA approvals for digital pathology systems in the US, is also further encouraging the US digital pathology market growth. For instance, In April 2017, Philips IntelliSite Pathology Solution (PIPS) receives the FDA clearance for digital pathology for primary diagnosis purpose in the US.  However, there are certain factors hindering the growth of US digital pathology market incudes regulatory issues, as FDA classify the WSI as Class-III device which pose to high risk.

Research Methodology

The market study of the US digital pathology market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for digital pathology software, service and devices manufacturers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US Digital Pathology Market Research and Analysis by Product and Services

2. US Digital Pathology Market Research and Analysis by End-user

3. US Digital Pathology Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the US Digital Pathology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Digital Pathology market.
• Insights about market determinants which are stimulating the US Digital Pathology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.